# 1. Financial Performance ## A. Key Figures * Revenue Growth: 10% consolidated (+15% Europe, +13% Americas, +10% EAP, +1.7% AMESA) * **EBITDA Margin:** **20.5%** (12th consecutive quarter of expansion, 4th above 20%) * PAT Growth: 55.8% YoY · EPS: ₹3.13 (vs. ₹2.02 in Q1 FY’25) * Net Debt/EBITDA: 0.45x · ROCE: 18.9% ## B. Revenue Growth * **Broad-Based Momentum:** Double-digit regional growth in Europe, Americas, and EAP underpins strong consolidated top-line performance, despite AMESA headwinds from macro and FMCG demand weakness. ## C. EBITDA & Margins * **Sustained Margin Expansion:** 12th straight quarter of margin improvement driven by structural optimization, cost discipline, and favorable product mix in key markets. * **Strategic Shift:** Management realigned focus from cost control to growth execution after resolving prior-year organizational and P&L inefficiencies. ## D. PAT & EPS * **Earnings Leverage:** Underlying PAT and EPS growth reflect strong EBITDA conversion and cash flow strength, with tax rate expected to trend near **18–20%** amid favorable geographic profit mix. ## E. Balance Sheet * **Improved Capital Efficiency:** Healthy deleveraging and rising ROCE signal stronger financial resilience and improved return profile post-structural turnaround. --- # 2. Product & Segment Performance ## A. Key Figures * **Beauty & Cosmetics Growth:** **35%** YoY · **35%** YoY * **Sustainable Tube Sales Mix:** **38%** of total sales ## B. Beauty & Cosmetics Segment * **Strong Double-Digit Momentum:** Beauty & Cosmetics segment delivered robust growth, driven by innovation with existing and new customers, particularly **D2C and online brands** in India. * **Global Expansion Signal:** Expansion in Brazil underscores confidence in sustained demand, with B&C being a key contributor to global performance. * **Outlook Remains Strong:** Management expects growth to remain firmly in the double-digit range, supported by capacity investments and recovery in adjacent categories like oral care. ## C. Sustainable Formats * **Sustainability as Competitive Edge:** Sustainable tube formats now represent a significant portion of sales, acting as a commercial differentiator in client engagements. * **Innovation Driving Adoption:** Growth in sustainable mix fueled by co-development of **recyclable and PCR-based solutions**, enhancing wallet share and bid competitiveness. --- # 3. Geography & Demand ## A. Key Figures * **Revenue Growth:** **Double-digit growth** in three regions outside India * **Margin Performance:** **Significant improvement** in Europe and the Americas · **Target-range margins** maintained in AMESA and EAP ## B. Europe & Americas * **Turnaround Underway:** Strong margin and revenue recovery in Europe driven by **structural changes**, enhanced sales capacity, and new leadership, reversing prior underperformance. * **Growth Resilience:** Outperformance persists despite softer category trends, with upside seen from low base and **service-led expansion potential**. * **Tariff Navigation:** Americas recovered from prior U.S. tariff headwinds and are actively assessing impact of new duties. ## C. AMESA Region * **Stable Execution:** AMESA and EAP held margins within target range through disciplined operations, supporting consolidated profitability. ## D. India Performance * **Product Mix Shift:** Tube revenue growth outpaced overall growth, signaling normalization in laminate inventory levels. --- # 4. Capacity & Expansion ## A. Key Figures * **Thailand Capex:** **$5 Mn** initial investment (leased facility) * **Annual Capex:** **₹350–400 Cr** ongoing growth investments * **Volume Growth:** **High-single-digit** YoY volume expansion ## B. Brazil Operations * **Outperformance in Brazil:** Greenfield facility now fully operational and exceeding targets, with beauty and cosmetics capacity doubled to meet strong demand. * **Strategic Scaling:** High utilization in Brazil validates expansion model and supports new customer acquisition and improved service levels. ## C. Thailand Greenfield * **On-Schedule Thailand Ramp-Up:** Facility on track to contribute in H2, targeting the large local tube market with onshore production for better lead times and access to **larger-diameter tubes**. * **Independent Yet Supported Model:** EPL to operate autonomously with its own sales team, backed by Indorama’s support in licensing and market access—**no competitive overlap**, potential for synergy. * **Low-Risk Strategic Entry:** Small initial capex and scalable model position Thailand as a springboard for broader regional expansion if successful. ## D. Growth Capex & Operational Enhancements * **Capex Discipline:** Sustained investment at ₹350–400 Cr annually focused on high-growth geographies and capacity expansion. * **Agility Improvements:** Back-end upgrades and talent investments enable **faster delivery of smaller MOQs**, enhancing competitiveness. --- # 5. Customer & Innovation ## A. Key Figures * **Personal Care Growth:** **28%** YoY on strong base ## B. New Customer Acquisition * **Growth Drivers:** Robust personal care segment expansion driven by aggressive customer acquisition and innovation, led by the Neo-seam product line. * **Innovation Confidence:** Management underscores innovation as the core engine of B&C growth, underpinning expectations for sustained momentum despite lack of granular customer contribution data. ## C. Product Innovation * **Sustainability Leadership:** EPL achieved an **A rating from CDP** for supplier engagement for the **third consecutive year**, reinforcing its ESG leadership across the value chain. ## D. Service-Led Growth * **Strategic Execution:** Personal care momentum reflects successful company-wide deployment of strategies, with global rollout and deeper operational penetration now translating into results. --- # 6. M&A & Strategic Partnerships ## A. M&A Strategy & Targets * **Active Global M&A Pursuit:** The company is actively evaluating beauty and cosmetics (B&C) acquisition targets globally, with a focus on geographic expansion and extruded tube manufacturers in dominant markets, all within the plastic tubes segment. * **Strategic Intent:** B&C is positioned as a major growth driver, with M&A serving as a key lever to accelerate scale and market access, particularly in Europe to address low current share and capture opportunity via improved service. * **Deal Activity Underway:** Several NDAs have been signed, signaling advanced exploration of inorganic opportunities in strategic geographies, though no details on size or valuation are disclosed. * **Balance Sheet Flexibility:** No fixed acquisition budget is set, but a debt-to-EBITDA ratio of **45** provides capacity to pursue medium to large-sized deals. ## B. Indorama Collaboration * **Operational Synergy in Thailand:** Indorama’s strategic investment is enabling accelerated execution, with EPL’s new unit being built on Indorama’s premises in Thailand under arm’s length terms, supported by expedited licensing and approvals. * **Strategic Investor Alignment:** Indorama was selected to support long-term transformational growth and value creation, with a focus on sustainable decision-making over short-term returns, differentiating it from private equity. * **Expansion of Partnership:** Beyond Thailand, EPL is actively exploring additional global collaboration opportunities with Indorama, indicating deepening strategic integration. --- # 7. Risks & Category Trends ## A. Category Performance Trends * **Oral Care Softness Persists in AMEA:** AMEA region faces **four consecutive quarters** of subdued growth, with oral care category weakness continuing to weigh on performance. * **Diverging Category Dynamics:** While oral care volumes remain weak, **accelerated momentum in beauty and cosmetics** is offsetting declines and supporting overall growth. * **Resilience Amid Downturn:** Company delivered double-digit growth despite headwinds from soft oral care demand, underscoring diversification and strength in adjacent categories. * **Short-Term Nature Expected:** Management views oral care softness as temporary, citing the category’s **essential usage** and structural resilience. --- # 8. Guidance & Outlook ## A. Key Figures * **Revenue Guidance:** **Double-digit growth** expected for full year · **EBITDA growth > Revenue growth** · **PAT growth > EBITDA growth** ## B. Full-Year Revenue * **Strategic Focus:** Growth to be driven by market expansion, product innovation, and margin enhancement, with clear execution priorities. * **Performance Trajectory:** Management emphasizes annual (not quarterly) cadence for delivering on profitability leverage targets. ## C. Profit Growth Outlook * **H2 2025 Recovery Expected:** Improved financial performance anticipated on the back of customer-led recovery signals and **accelerated momentum in beauty & cosmetics**. * **Sustained Personal Care Strength:** Growth in personal care segment seen as durable over next 12 months despite softness in broader Indian FMCG demand.